Detalles de la búsqueda
1.
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 24(8): 881-891, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451291
2.
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Lancet Oncol
; 23(10): 1297-1307, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063830
3.
Radiological Response and Neutrophil-to-Lymphocyte Ratio as Predictive Factors for Progression-Free and Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib.
Adv Exp Med Biol
; 1153: 31-45, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30903615
4.
Hand-Foot Syndrome and Progression-Free Survival in Patients Treated with Sunitinib for Metastatic Clear Cell Renal Cell Carcinoma.
Adv Exp Med Biol
; 1133: 35-40, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30701441
5.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 19(7): 975-986, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880291
6.
Chemotherapy-Induced Takotsubo Syndrome.
Adv Exp Med Biol
; 1114: 19-29, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884920
7.
Serous Carcinoma of the Uterine Cervix, an Extremely Rare Aggressive Entity: A Literature Review.
Gynecol Obstet Invest
; 83(3): 220-226, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393245
8.
Radiotherapy in testicular germ cell tumours - a literature review.
Contemp Oncol (Pozn)
; 21(3): 203-208, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29180926
9.
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 16(4): 417-25, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25743937
10.
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.
Lancet Oncol
; 15(7): 738-46, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24836273
11.
Prognostic factors in patients undergoing lymphadenectomy for squamous cell carcinoma of the penis.
Urol Int
; 92(2): 194-201, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24051343
12.
A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer.
Eur J Cancer
; 202: 114007, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518534
13.
Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?
Psychooncology
; 22(2): 346-51, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22081540
14.
Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first-line chemotherapy.
Cancer Med
; 12(18): 18542-18556, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584231
15.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 546-552, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142815
16.
RRM2 gene expression depends on BAF180 subunit of SWISNF chromatin remodeling complex and correlates with abundance of tumor infiltrating lymphocytes in ccRCC.
Am J Cancer Res
; 11(12): 5965-5978, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35018236
17.
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma.
J Clin Oncol
; 39(9): 1029-1039, 2021 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33529058
18.
What is the damage? Testicular germ cell tumour survivors deficient in testosterone at risk of metabolic syndrome and a need for medical intervention.
Med Oncol
; 37(9): 82, 2020 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32767179
19.
The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC).
Med Oncol
; 36(2): 19, 2019 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666498
20.
Venous thromboprophylaxis in urological cancer surgery.
Med Oncol
; 37(1): 11, 2019 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31768889